These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 18029957)

  • 1. Introduction to the new prescription drug labeling by the Food and Drug Administration.
    Lal R; Kremzner M
    Am J Health Syst Pharm; 2007 Dec; 64(23):2488-94. PubMed ID: 18029957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Requirements on content and format of labeling for human prescription drug and biological products. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2006 Jan; 71(15):3921-97. PubMed ID: 16479698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Requirements for submission of labeling for human prescription drugs and biologics in electronic format. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2003 Dec; 68(238):69009-20. PubMed ID: 14672084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Content and format of labeling for human prescription drug and biological products; requirements for pregnancy and lactation labeling. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2014 Dec; 79(233):72063-103. PubMed ID: 25509060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescription drug product labeling; medication guide requirements--FDA. Final rule.
    Fed Regist; 1998 Dec; 63(230):66378-400. PubMed ID: 10338877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Food and Drug Administration--Prescription drug products; patient package inserts requirements. Final rule.
    Fed Regist; 1980 Sep; 45(179 Pt 2):60754-84. PubMed ID: 10248285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supplemental applications proposing labeling changes for approved drugs, biologics, and medical devices. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2008 Aug; 73(164):49603-10. PubMed ID: 18958946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiperspirant drug products for over-the-counter human use; final monograph. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2003 Jun; 68(110):34273-93. PubMed ID: 12795305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Over-the-counter human drugs; labeling requirements. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 1999 Mar; 64(51):13254-303. PubMed ID: 10557606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The product label: how pharmacokinetics and pharmacodynamics reach the prescriber.
    Marroum PJ; Gobburu J
    Clin Pharmacokinet; 2002; 41(3):161-9. PubMed ID: 11929317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The new Food and Drug Administration drug package insert: implications for patient safety and clinical care.
    Watson KT; Barash PG
    Anesth Analg; 2009 Jan; 108(1):211-8. PubMed ID: 19095852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Over-the-counter human drugs; labeling requirements; final rule; technical amendment. Food and Drug Administration, HHS. Final rule; technical amendment.
    Fed Regist; 2000 Jan; 65(1):7-9. PubMed ID: 11010625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The FDA announces new prescription drug information format.
    FDA Consum; 2006; 40(2):25-7. PubMed ID: 16671197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Labeling and effectiveness testing; sunscreen drug products for over-the-counter human use; delay of compliance dates. Final rule; delay of compliance dates; request for comments.
    Food and Drug Administration, HHS
    Fed Regist; 2012 May; 77(92):27591-3. PubMed ID: 22606729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The US FDA pregnancy lactation and labeling rule - Implications for maternal immunization.
    Gruber MF
    Vaccine; 2015 Nov; 33(47):6499-500. PubMed ID: 26256527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Drug Labels Following the 2015 Pregnancy and Lactation Labeling Rule.
    Byrne JJ; Saucedo AM; Spong CY
    JAMA Netw Open; 2020 Aug; 3(8):e2015094. PubMed ID: 32865574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FDA approval of comparative claims for prescription drugs--the Moxam case.
    Marcus D
    Drug Inf J; 1983; 17(3):171-5. PubMed ID: 10265094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Off-label or out of bounds? Prescriber and marketer liability for unapproved uses of FDA-approved drugs.
    O'Reilly J; Dalal A
    Ann Health Law; 2003; 12(2):295-324, table of contents. PubMed ID: 12856461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDA's proposed regulations to expand access to investigational drugs for treatment use: the status quo in the guise of reform.
    Rossen BR
    Food Drug Law J; 2009; 64(1):183-223. PubMed ID: 19998746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bar code label requirement for human drug products and biological products. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2004 Feb; 69(38):9119-71. PubMed ID: 14986679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.